Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.
Info & Links
CEO
Scott G. Davis
Headquarters
101 GLACIER POINT, SUITE A SAN RAFAEL, CA 94901, UNITED STATES
Ekso Bionics Holdings, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
10.60M
Enterprise Value
9.21M
Enterprise Value/EBITDA(ttm)
-1.04
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
0.70
Price to Book(mrq)
0.83
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
53.01%
Operating Margin(ttm)
-62.95%
Profit Margin(ttm)
-64.33%
Return on Equity(ttm)
-83.09%
Return on Invested Capital(ttm)
-64.64%
Return on Assets(ttm)
-39.03%
Income Statement
Revenue(ttm)
17.93M
Revenue Per Share(ttm)
0.72
Gross Profit(ttm)
9.51M
EBITDA(ttm)3
-8.85M
Net Income Available to Common(ttm)
-11.33M
Diluted EPS(ttm)
-0.65
Share Statistics
Beta (5Y Monthly)
1.46
52-Week Change
-69.43%
S&P 500 52-Week Change
3.55%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
24.82M
Dividend Yield
0.00%
Float4
20.66M
% Held by Insiders
6.10%
% Held by Institutions
6.42%
Balance Sheet
Total Cash(mrq)
6.49M
Total Cash Per Share(mrq)
0.26
Total Debt(mrq)
5.10M
Total Debt/Equity(mrq)
40.17%
Current Ratio(mrq)
2.50%
Quick Ratio(mrq)
2.14%
Book Value Per Share(mrq)
0.57
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.49
Free Cash Flow(ytd)
-9.85M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.